Anti-Polyoma virus, Medium T antigen antibody [PyMT] (ab15085)

Publishing research using ab15085? Please let us know so that we can cite the reference in this datasheet.

ab15085 has been referenced in 9 publications.

  • Kim J  et al. Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. Cancer Res 76:6424-6435 (2016). ICC/IF . PubMed: 27569213
  • Roy A  et al. Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma. PLoS One 11:e0156151 (2016). PubMed: 27223472
  • Thienpont B  et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature 537:63-68 (2016). IF . PubMed: 27533040
  • Cunha SI  et al. Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer. Cancer Res 75:2445-56 (2015). PubMed: 26077471
  • Fischer KR  et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527:472-6 (2015). IF . PubMed: 26560033
  • Harmsen S  et al. Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging. Sci Transl Med 7:271ra7 (2015). PubMed: 25609167
  • Samén E  et al. Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ. EJNMMI Res 4:17 (2014). IF . PubMed: 24670127
  • Dilworth SM & Griffin BE Monoclonal antibodies against polyoma virus tumor antigens. Proc Natl Acad Sci U S A 79:1059-63 (1982). PubMed: 6175960
  • Dilworth SM Protein kinase activities associated with distinct antigenic forms of polyoma virus middle T-antigen. EMBO J 1:1319-28 (1982). PubMed: 6327264

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up